We develop a digital platform that will help customers, both private and business, to get quick, professional, competitive, and fully transparent renovation services for apartments. Our tool has a project management system, the possibility for the financing of renovation, payment solution, insurance, resolution center, task delegation, and material handling, in addition to the quick order process with defined packages and styles you will need. We have 20 years of experience in the renovation of flats, renovated more than 150 apartments, and have contractors on the team. Our MVP is now finished, and we will start development soon on the complete solution, covering all functionalities. We are looking for investors.

Migraine is an underdiagnosed and undertreated brain disease. 1 in 7 people worldwide is affected by migraine. Nordic Brain Tech develops a treatment that is home-based and self-administered. The invention has gotten worldwide attention from key opinion leaders within migraine. There is a huge market need, and a willingness to pay for the product from both hospitals and migraine patients.

Tinymesh™ holds a unique position in the fast-growing Indian market for smart energy metering & smart street light connectivity. Driven by high demand growth, the company expects revenue of $39 million with >40% profitability margin in 2022. Substantial orders proving the solution, quality, and trust in smart energy metering and smart street lighting segments were signed in Q2-2019. Demand-side is escalating and Tinymesh is inviting investors ready to scale with the company.

Coleapri is a Norway based research and technology company. We seek inspiration from nature to create efficient technical solutions that are less harmful to the environment. The company has developed cutting-edge technologies in the field of  transportation of fluids, energy conversion and marine propulsion. The technology has a level of efficiency and competitive advantages well beyond anything currently achievable by conventional devices

The Electrical Vehicle market in Norway is exploding and more than every 2nd car sold is now electric. With this also the accessories market is exploding. Besen Group AS is a "spinoff" from Grønne Mil AS which created the market standard for sales of electric vehicle accessories to consumers in Norway already in 2015. While Grønne Mil AS is a B2C business offering a wide scope of products, Besen Group AS is a local agent and distributor of the largest cables and charging station producer in China, Besen International Group AS. The aim is to cover the entire value chain with both Besen Group AS in Norway and Grønne Mil AS. Besen Group International in China is transferring customers for local handling and development.

Elife E-bikesWe design and import components directly from industries (Germany etc.) and handmake e-bikes in Norway. This is the 3 rd year for us, we have our shop in Oslo and started our focus on developing&producing. We have distributors in Norway and Iceland. Our advantage is that all our competitors can be potential partners. In 2018, we have handmade the lightest three-seater "e-bike-car" in the world - iCloud. It allows 2 People to pedal at the same time. It protects you from bad weather & has a 150L trunk. Its battery range is 200km.

Ose Water AS is a Norwegian bottled water and bag-in-box water producer.The water source is Ose which provides high quality natural mineral water. The company aim to be in production for international sale in Q1 2019. Ose Water AS is a producer of natural mineral water from the Ose spring in Bygland municipality, Aust-Agder county in Norway.

Visito AS er en Bergensbasert IT-virksomhet med erfarne konsulenter som jobber i grensesnittet mellom teknologi og forretning. Vi hjelper kundene våre med å levere viktige prosjekter på en smidig og effektiv måte, og med riktig nivå av kvalitet. Våre tjenester inkluderer teknisk prosjektledelse, rådgivning, arkitektur, infrastruktur og kvalitetssikring. Vi opptrer profesjonelt og med en åpen, uformell og inkluderende tilnærming. Vi har høye krav til integritet og ryddighet.

We have developed a system for calculating and supplying Solcelle, and wind power for Scandinavia. In addition to this, we have obtained a license as a power supplier, so we can offer our customers both purchases and sales of green power. Why solar cells? Sun provides energy. As an energy source, the sun is unsurpassed. Every year, the earth receives 15,000 times more energy from the sun than the earth's population uses. Even in Norway, the sun provides 1,500 times more energy than what we use. Depending on where on the globe you are, the sun provides an amount of energy from 700 to over 2,200 kWh/m2 per year.

Amina Charging is a technology startup on a mission to give our planet a greener future by scaling the transition to electric vehicles (EV). We create environmental sustainability solutions grounded in sound business and global scalability. We work and play with curiosity, creativity and ambition. At Amina, we never compromise on sustainability, scale and sound business. We work with passion and insight, and prize impact and progress over process. We empower your creative autonomy but you will never struggle alone. We work as a team in an open culture that rewards sharing ideas and supporting each other.

Move is an IT infrastructure consulting company and system integrator covering the areas of Network and Security, Virtualization, Database and OS platforms, and high-end server/storage. Move delivers: High expertise advisor and consultancy services Design and implementation of complex projects Diversified service and support services Project Management IT-solutions

The Founder Institute is the world’s premier startup launch program for talented entrepreneurs. If you are up to the challenge, our comprehensive step-by-step program will give you the structure, mentor support, and network of entrepreneurs you need to start an enduring company. Based in Silicon Valley and with chapters across 60 countries, the Founder Institute's mission is to "Globalize Silicon Valley" and build sustainable startup ecosystems worldwide.

EpiGuard AS is an innovative Norwegian Medical Technology Company established in 2015 by a group of doctors at the Oslo University Hospital (OUS) together with co-founders Inven2, Eker Group AS, and Hansen Protection AS. EpiGuard has evolved into a highly skilled knowledge-based company. The business model is to develop and manufacture high-end medical equipment for the safe transport of contagious patients. The products will be distributed globally through strategic partners. Currently, the main product is the medical isolation and transportation system, EpiShuttle. The system is developed by clinical experts at OUS, with first-hand experience in providing advanced treatment and transportation of patients with highly infectious diseases, such as Ebola.

Oncoinvent AS is a privately held Norwegian company established in 2010. The company is committed to developing new innovative products to provide better treatment options to cancer patients. The innovations being developed by Oncoinvent AS are a result of the extensive experience with the development of radionuclide-based cancer treatments of two of the founders, Dr. Roy H. Larsen and Professor of clinical oncology Øyvind S. Bruland. Larsen and Bruland are the inventors of the first FDA and EMA-approved alpha-emitting pharmaceutical product Xofigo® (Bayer AG), as well as of the beta-emitting radio-immunotherapeutic product candidate Betalutin® (Nordic Nanovector ASA). Oncoinvent's lead product candidate, Radspherin®, is a novel alpha-emitting radioactive microsphere designed for the treatment of metastatic cancers in body cavities. Radspherin® has been shown to cause a significant reduction in tumor cell growth. It is anticipated that the product can potentially treat several forms of metastatic cancer. The first clinical indication for Radspherin® will be the treatment of peritoneal carcinomatosis. Clinical development will be conducted in collaboration with European and American clinical research centers.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.